A close look at fenfluramine and dexfenfluramine

The Journal of Emergency Medicine
L E ViveroR F Clark

Abstract

In an effort to combat obesity, several medications have been developed. The nonamphetamine anorectics, such as phentermine, fenfluramine, and dexfenfluramine, have been recommended as first-line drug therapy for the treatment of obesity once diet and exercise alone have failed. Numerous studies have shown that these agents can promote weight loss when combined with diet restriction and exercise. Although fenfluramine and dexfenfluramine lack the abuse potential of amphetamine and its congeners, these agents are associated with drug interactions and adverse effects. Concomitant administration of fenfluramine or dexfenfluramine with medications that enhance serotonin levels (e.g., antidepressants, monoamine oxidase inhibitors, and migraine medications) can precipitate serotonin syndrome. Sudden discontinuation of fenfluramine or dexfenfluramine after prolonged administration can precipitate withdrawal depressive symptoms. Primary pulmonary hypertension, a potentially fatal disorder, has been reported to occur approximately 30 times more frequently in patients receiving anorectic agents for more than 3 months compared to the general population. More recently, the association of these popular anorectics with valvular heart disease...Continue Reading

References

Jul 1, 1975·The Journal of Pediatrics·J C Veltri, A R Temple
Feb 15, 1992·Lancet·P G AtanassoffM Tornic
May 1, 1992·Clinical Pharmacology and Therapeutics·M WeintraubL Byrne
May 1, 1992·Clinical Pharmacology and Therapeutics·M WeintraubC Cox
May 1, 1992·Clinical Pharmacology and Therapeutics·M WeintraubB Schuster
Nov 11, 1989·Lancet·B Guy-GrandP Turner
May 19, 1989·European Journal of Pharmacology·R InvernizziR Samanin
Mar 10, 1973·Lancet·A StunkardP Hesbacher
Mar 8, 1969·Lancet·G L Pawan
Dec 13, 1969·Lancet·D B Campbell, B W Moore
Jul 10, 1971·British Medical Journal·S A LewisD L Dunleavy
Jan 1, 1972·Current Medical Research and Opinion·D C CameronG K Crompton
Mar 1, 1973·La Vie médicale au Canada français·J P Sedgwick
Apr 1, 1974·Archives of Disease in Childhood·J M Darmady
Jul 1, 1972·British Medical Journal·J M Steel, M Briggs
Jul 10, 1971·British Medical Journal·I OswaldM Briggs
Jan 24, 1970·British Medical Journal·D V Hawks
Apr 18, 1970·British Medical Journal·N W Imlah
Oct 1, 1970·Acta Medica Scandinavica·J MalmquistC Lindström
May 12, 1984·The Medical Journal of Australia·J CameronD J Radford
Oct 3, 1981·British Medical Journal·J G DouglasA T Proudfoot
Nov 21, 1981·British Medical Journal·M S Wheeley
Sep 14, 1995·The New England Journal of Medicine·J E MansonF E Speizer
Sep 1, 1995·The American Journal of Medicine·P HervéL Drouet
Apr 1, 1994·Pathology International·Y Hosoda
Dec 1, 1993·British Heart Journal·F BrenotG Simonneau
Oct 1, 1993·Annals of Internal Medicine·F X Pi-Sunyer
Dec 1, 1995·British Heart Journal·S H ThomasP C Waller
Feb 13, 1997·The New England Journal of Medicine·J Sobieraj
Aug 28, 1997·The New England Journal of Medicine·H M ConnollyH V Schaff
Aug 28, 1997·The New England Journal of Medicine·D J Graham, L Green
Dec 31, 1997·The New England Journal of Medicine·P D Thompson
Apr 1, 1965·The Journal of Pharmacy and Pharmacology·B V FRANKOJ W WARD

❮ Previous
Next ❯

Citations

Nov 26, 2002·European Journal of Pharmacology·Thomas J Connor, John P Kelly
Aug 26, 2000·Current Opinion in Chemical Biology·L H Van der Ploeg
Mar 31, 2011·Drug Design, Development and Therapy·Nicholas T Bello, Nu-Chu Liang
Nov 3, 2010·Neuroscience and Biobehavioral Reviews·Eoin C O'ConnorAndy N Mead
Apr 24, 2013·Nutrition Research and Practice·Jongmi BaekMyeon Choe
May 5, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Elizabeth J MeredithJohn Gordon
Dec 10, 2016·Frontiers in Neuroscience·Giuseppe Di GiovanniPhilippe De Deurwaerdère
Jul 18, 2001·Journal of Applied Physiology·S BelohlávkováV Hampl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved